Commit To Purchase OncoMed Pharmaceuticals At $10, Earn 29.6% Annualized Using Options

Investors considering a purchase of OncoMed Pharmaceuticals Inc. (OMED) stock, but tentative about paying the going market price of $12.31/share, might benefit from considering selling puts among the alternative strategies at their disposal..
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.